Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Akaza

Showing results (141-150 of 293) with videos related to

Pageof 30
Sort By:
Urology|December 18, 2001
Progress in prostate cancer chemoprevention: modulators of promotion and progressionR Lieberman, C Bermejo, H Akaza, et al.
Japanese Journal of Clinical Oncology|September 8, 1998
Effects of soybean isoflavones on cell growth and apoptosis of the human prostatic cancer cell line LNCaPM Onozawa, K Fukuda, M Ohtani, et al.
Japanese Journal of Clinical Oncology|June 1, 1992
Long-term clinical study on luteinising hormone-releasing hormone agonist depot formulation in the treatment of stage D prostatic cancer. The TAP-144-SR Study GroupH Akaza, M Usami, K Koiso, et al.
European Urology|January 1, 1997
Promoting effects and mechanisms of action of androgen in bladder carcinogenesis in male ratsS Imada, H Akaza, Y Ami, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Additive effects of antitumor drugs and lymphokine-activated killer cell cytotoxic activity in tumor cell killing determined by lactate-dehydrogenase-release assayK Kawai, T Sasaki, K Saijo-Kurita, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|June 1, 1993
[Histopathological comparison of prostatic adenocarcinoma in Japan and the United States]M Harada, R Nemoto, K Uchida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1997
[Bropirimine (U-54461S) late phase II clinical study for carcinoma in situ of the bladder. Japan Bropirimine Study Group]H Akaza, J Shimazaki, K Tashiro, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 20, 1999
[Cases of refractory testicular cancer treated with all trans-retinoic acid]K Iida, K Kawai, H Hayashi, et al.
Hinyokika Kiyo. Acta Urologica Japonica|February 24, 2001
[A randomized long-term comparative study of clinical efficacy of alpha 1-blocker with or without antiandrogen therapy for benign prostatic hyperplasia: focusing on improvement of I-PSS]M Ohtani, K Kikuchi, A Tsuchiya, et al.
Hinyokika Kiyo. Acta Urologica Japonica|October 3, 2001
[A case of transitional cell carcinoma of the urinary bladder with high serum level of CEA and CA19-9]H Inai, T Shimazui, T Yamamoto, et al.
Pageof 30

Showing results (141-150 of 293) with videos related to

Sort By:
Pageof 30
Urology|December 18, 2001
Progress in prostate cancer chemoprevention: modulators of promotion and progressionR Lieberman, C Bermejo, H Akaza, et al.
Japanese Journal of Clinical Oncology|September 8, 1998
Effects of soybean isoflavones on cell growth and apoptosis of the human prostatic cancer cell line LNCaPM Onozawa, K Fukuda, M Ohtani, et al.
Japanese Journal of Clinical Oncology|June 1, 1992
Long-term clinical study on luteinising hormone-releasing hormone agonist depot formulation in the treatment of stage D prostatic cancer. The TAP-144-SR Study GroupH Akaza, M Usami, K Koiso, et al.
European Urology|January 1, 1997
Promoting effects and mechanisms of action of androgen in bladder carcinogenesis in male ratsS Imada, H Akaza, Y Ami, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Additive effects of antitumor drugs and lymphokine-activated killer cell cytotoxic activity in tumor cell killing determined by lactate-dehydrogenase-release assayK Kawai, T Sasaki, K Saijo-Kurita, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|June 1, 1993
[Histopathological comparison of prostatic adenocarcinoma in Japan and the United States]M Harada, R Nemoto, K Uchida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1997
[Bropirimine (U-54461S) late phase II clinical study for carcinoma in situ of the bladder. Japan Bropirimine Study Group]H Akaza, J Shimazaki, K Tashiro, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 20, 1999
[Cases of refractory testicular cancer treated with all trans-retinoic acid]K Iida, K Kawai, H Hayashi, et al.
Hinyokika Kiyo. Acta Urologica Japonica|February 24, 2001
[A randomized long-term comparative study of clinical efficacy of alpha 1-blocker with or without antiandrogen therapy for benign prostatic hyperplasia: focusing on improvement of I-PSS]M Ohtani, K Kikuchi, A Tsuchiya, et al.
Hinyokika Kiyo. Acta Urologica Japonica|October 3, 2001
[A case of transitional cell carcinoma of the urinary bladder with high serum level of CEA and CA19-9]H Inai, T Shimazui, T Yamamoto, et al.
Pageof 30